PAR 2.50% 20.5¢ paradigm biopharmaceuticals limited..

PAR and the Possible Sales Projection, page-5

  1. 1,058 Posts.
    lightbulb Created with Sketch. 219
    Thanks for the reminder Happell Probably best to keep a balanced outlook. I'll try...

    It's very hard with PAR to keep the bias getting out of control. But then I think is it bias or is it just that the fundamentals of this business justify a very positive outlook. This stock has got me like no other.

    We have a pretty rock solid leadership with big pharma experience. I feel they will be able to guide us through to a big pharma partnership. The potential is far too great to let a takeover occur. They have been in partnership discussions for a while now, it's all about timing to get the best deal.

    DYOR

    PharmD
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
0.005(2.50%)
Mkt cap ! $71.79M
Open High Low Value Volume
20.0¢ 20.5¢ 19.5¢ $166.0K 831.1K

Buyers (Bids)

No. Vol. Price($)
9 84891 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 48716 7
View Market Depth
Last trade - 14.00pm 07/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.